Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L31 pseudogene 60 (RPL31P60)** is classified as a pseudogene, not a functional protein-coding gene[3][6]. It shares sequence similarity with the ribosomal protein L31 gene (RPL31), which encodes a component of the large 60S ribosomal subunit involved in protein synthesis[1][2][5]. However, as a pseudogene, RPL31P60 does not produce a functional protein, and there is no evidence linking it to therapeutic targeting, drug interactions, or disease biology[3][6]. No established biological function, disease association, or therapeutic relevance has been reported for this pseudogene. **Key notes:** - **Is_incorrect is true:** This entry describes a pseudogene, not a functional therapeutic target. - **RPL31 (not RPL31P60) is the functional gene.** - No evidence supports its role as a drug target, biomarker, or disease-associated locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L31 pseudogene 60 (RPL31P60).